| Drug Name: | Dihydroergocryptine (25447-66-9) |
|---|---|
| PubChem ID: | 114948 |
| SMILES: | CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]3(N1C(=O)[C@](O3)(C(C)C)NC(=O)[C@@H]4C[C@H]5[C@@H](CC6=CNC7=CC=CC5=C67)N(C4)C)O |
| InchiKey: | PBUNVLRHZGSROC-VTIMJTGVSA-N |
| Therapeutic Category: | Cardiovascular Agents, Dopamine Agents, Dopamine Agonists, Neurotransmitter Agents, Vasodilator Agents |
| Molecular Weight (dalton) | : | 577.726 |
| LogP | : | 2.5206 |
| Ring Count | : | 2 |
| Hydrogen Bond Acceptor Count | : | 6 |
| Hydrogen Bond Donor Count | : | 3 |
| Total Polar Surface Area | : | 118.21 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|